|
US669236A
(en)
*
|
1900-02-16 |
1901-03-05 |
Frank M Garland |
Automatic machine-gun.
|
|
US3922379A
(en)
*
|
1973-12-17 |
1975-11-25 |
Abbott Lab |
Microencapsulation process
|
|
FR2473525A1
(fr)
|
1980-01-11 |
1981-07-17 |
Roussel Uclaf |
Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
DE3174858D1
(en)
*
|
1980-12-25 |
1986-07-24 |
Fujitsu Ltd |
Nonvolatile semiconductor memory device
|
|
JPS60214796A
(ja)
|
1984-04-06 |
1985-10-28 |
Taisho Pharmaceut Co Ltd |
６−０−メチルエリスロマイシン類の製法
|
|
JPS61103890A
(ja)
|
1984-10-26 |
1986-05-22 |
Taisho Pharmaceut Co Ltd |
６−０−メチルエリスロマイシンａ誘導体
|
|
DE3583799D1
(de)
*
|
1985-01-11 |
1991-09-19 |
Abbott Lab Ltd |
Feste zubereitung mit langsamer freisetzung.
|
|
US4670549A
(en)
|
1985-03-18 |
1987-06-02 |
Taisho Pharmaceutical Co., Ltd. |
Method for selective methylation of erythromycin a derivatives
|
|
US4672056A
(en)
|
1985-11-12 |
1987-06-09 |
Abbott Laboratories |
Erythromycin A derivatives and method of use
|
|
US4640910A
(en)
|
1985-11-12 |
1987-02-03 |
Abbott Laboratories |
Erythromycin A silylated compounds and method of use
|
|
KR960000434B1
(ko)
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
US4808411A
(en)
*
|
1987-06-05 |
1989-02-28 |
Abbott Laboratories |
Antibiotic-polymer compositions
|
|
GB8721165D0
(en)
|
1987-09-09 |
1987-10-14 |
Beecham Group Plc |
Chemical compounds
|
|
JP2751385B2
(ja)
|
1988-05-19 |
1998-05-18 |
大正製薬株式会社 |
エリスロマイシンａオキシム及びその塩の製造方法
|
|
IT1246383B
(it)
*
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per il mascheramento del sapore di farmaci
|
|
GB9120131D0
(en)
*
|
1991-09-20 |
1991-11-06 |
Glaxo Group Ltd |
Medicaments
|
|
JP3265680B2
(ja)
*
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
|
TW276996B
(enExample)
*
|
1992-04-24 |
1996-06-01 |
Astra Ab |
|
|
EP0650353B1
(en)
*
|
1992-06-04 |
2002-05-22 |
Smithkline Beecham Corporation |
Palatable pharmaceutical compositions
|
|
US5919489A
(en)
*
|
1995-11-01 |
1999-07-06 |
Abbott Laboratories |
Process for aqueous granulation of clarithromycin
|
|
US5756473A
(en)
|
1995-11-21 |
1998-05-26 |
Abbott Laboratories |
6-O-methyl erythromycin D and process for making
|
|
US5872229A
(en)
|
1995-11-21 |
1999-02-16 |
Abbott Laboratories |
Process for 6-O-alkylation of erythromycin derivatives
|
|
US5705190A
(en)
*
|
1995-12-19 |
1998-01-06 |
Abbott Laboratories |
Controlled release formulation for poorly soluble basic drugs
|
|
US5998194A
(en)
*
|
1995-12-21 |
1999-12-07 |
Abbott Laboratories |
Polyketide-associated sugar biosynthesis genes
|
|
US5837829A
(en)
|
1996-04-02 |
1998-11-17 |
Abbott Laboratories |
9-oximesilyl erythromycin a derivatives
|
|
US5719272A
(en)
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
US5808017A
(en)
|
1996-04-10 |
1998-09-15 |
Abbott Laboratories |
Process for preparing erythromycin A oxime
|
|
AUPN969796A0
(en)
*
|
1996-05-07 |
1996-05-30 |
F.H. Faulding & Co. Limited |
Taste masked liquid suspensions
|
|
IL127833A
(en)
|
1996-07-29 |
2004-06-20 |
Abbott Lab |
Preparation of the crystalline form II of clarithromycin
|
|
US5844105A
(en)
|
1996-07-29 |
1998-12-01 |
Abbott Laboratories |
Preparation of crystal form II of clarithromycin
|
|
US5858986A
(en)
|
1996-07-29 |
1999-01-12 |
Abbott Laboratories |
Crystal form I of clarithromycin
|
|
US5972389A
(en)
*
|
1996-09-19 |
1999-10-26 |
Depomed, Inc. |
Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
|
|
US5945405A
(en)
|
1997-01-17 |
1999-08-31 |
Abbott Laboratories |
Crystal form O of clarithromycin
|
|
US5864023A
(en)
|
1997-02-13 |
1999-01-26 |
Abbott Laboratories |
3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
|
|
US6010718A
(en)
*
|
1997-04-11 |
2000-01-04 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US6551616B1
(en)
*
|
1997-04-11 |
2003-04-22 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US20050064033A1
(en)
*
|
1997-04-11 |
2005-03-24 |
Notario Gerard F. |
Extended release formulations of erythromycin derivatives
|
|
PT998271E
(pt)
*
|
1997-06-06 |
2005-10-31 |
Depomed Inc |
Formas de dosagem oral de farmacos com retencao gastrica para a libertacao controlada de farmacos altamente soluveis
|
|
US6635280B2
(en)
*
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
US5869098A
(en)
*
|
1997-08-20 |
1999-02-09 |
Fuisz Technologies Ltd. |
Fast-dissolving comestible units formed under high-speed/high-pressure conditions
|
|
US5929219A
(en)
*
|
1997-09-10 |
1999-07-27 |
Abbott Laboratories |
9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
|
|
US5852180A
(en)
|
1997-11-17 |
1998-12-22 |
Abbott Laboratories |
Chemical synthesis of 6-O-alkyl erythromycin A
|
|
US5932710A
(en)
|
1997-12-01 |
1999-08-03 |
Abbott Laboratories |
Process for preparing 6-O-alkyl-9-oxime erythromycin B
|
|
IL135792A0
(en)
*
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
US5892008A
(en)
|
1997-12-16 |
1999-04-06 |
Abbott Laboratories |
Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
|
|
KR100377159B1
(ko)
*
|
1998-09-09 |
2003-08-19 |
한미약품공업 주식회사 |
잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
|
|
CA2282066C
(en)
*
|
1999-06-29 |
2010-09-07 |
Smithkline Beecham Corporation |
Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
|
|
DE19950781A1
(de)
*
|
1999-10-21 |
2001-04-26 |
Knoll Ag |
Mehrteiliges Etikett für Durchdrückpackungen, seine Herstellung und Verwendung
|
|
KR100322313B1
(ko)
*
|
1999-10-21 |
2002-02-06 |
민경윤 |
클라리스로마이신 결정형 2의 제조방법 및 이에 사용되는 클라리스로마이신 포르메이트
|
|
KR100336447B1
(ko)
*
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
|
CN1217951C
(zh)
*
|
1999-12-16 |
2005-09-07 |
特瓦制药工业有限公司 |
克拉霉素多晶型物的制备方法和新的多晶型物iv
|
|
AU2001222619C1
(en)
*
|
2000-01-11 |
2006-01-12 |
Teva Pharmaceutical Industries Ltd. |
Processes for preparing clarithromycin polymorphs
|
|
YU64202A
(sh)
*
|
2000-02-29 |
2005-03-15 |
Teva Pharmaceutical Industries Ltd. |
Postupak za pripremanje klaritromicina i intermedijera klaritromicina, klaritromicina u osnovi bez oksima i farmaceutskog preparata koji ga sadrži
|
|
HUP0300418A3
(en)
*
|
2000-03-15 |
2003-09-29 |
Hanmi Pharm Co Ltd Hwaseong Gu |
Method of preparing clarithromycin of form ii crystals
|
|
US6488962B1
(en)
*
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
IN192748B
(enExample)
*
|
2000-08-29 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
ES2195727B1
(es)
*
|
2001-07-05 |
2005-03-01 |
Ercros Industrial, S.A. |
Un procedimiento para la obtencion de claritromicina.
|
|
WO2003017981A1
(en)
*
|
2001-08-29 |
2003-03-06 |
Ranbaxy Laboratories Limited |
Controlled release formulation of clarithromycin or tinidazol
|
|
US20050163857A1
(en)
*
|
2002-04-03 |
2005-07-28 |
Ashok Rampal |
Clarithromycin formulations having improved bioavailability
|
|
AU2003245504A1
(en)
*
|
2002-06-14 |
2003-12-31 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
|
US7063862B2
(en)
*
|
2003-06-03 |
2006-06-20 |
Biokey, Inc. |
Pharmaceutical composition and method for treating
|
|
US20050053658A1
(en)
*
|
2003-09-09 |
2005-03-10 |
Venkatesh Gopi M. |
Extended release systems for macrolide antibiotics
|